There is no amortization for the acquisition price for the U.S. Rights to CRINONE in the next quarter of 2011 due to the 2010 sale to Watson of these assets. Operating income in the next quarter of 2011 was $15.7 million, in comparison to an operating loss of $2.8 million in the last year period. The increase primarily reflects the $8.6 million in revenue related to the gain on the sale of the progesterone assets to Watson, the $5.0 million milestone payment from Watson for FDA acceptance of the NDA filing, plus a $7.1 million reduction in operating expenses. Various other income and expense aggregated to net income of $2.6 million for the second quarter of 2011, compared to a net expense of $1.4 million in the next quarter of 2010, in July 2010 primarily reflecting the elimination of interest expense as a result of the debt repayment.The experts say their evaluation of 32 research involving a lot more than 600,000 women supplies the strongest evidence however of such a web link and birth size might clarify 5 percent of all breasts cancers, suggesting some hyperlink between malignancy and the surroundings of the infant before birth. The brand new research, led by Professor of Epidemiology, Dr. Isabel dos Santos Silva, re-analysed the info from the research to obtain more specific estimates of the degree to which birth size impacts the chance of breast cancer afterwards in life also to investigate whether they could possibly be described by associations with various other risk elements.